Carregant...
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers
Eluxadoline, an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist developed for the treatment of diarrhea-predominant irritable bowel syndrome, normalizes gastrointestinal (GI) transit and defecation under conditions of novel environment stress or post-inflammato...
Guardat en:
| Publicat a: | Biochem Pharmacol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4769596/ https://ncbi.nlm.nih.gov/pubmed/25261794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2014.09.015 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|